Global Endobronchial Ultrasound Biopsy Market Growth (Status and Outlook) 2023-2029

Global Endobronchial Ultrasound Biopsy Market Growth (Status and Outlook) 2023-2029

EBUS (endobronchial ultrasound) bronchoscopy is a procedure used to diagnose different types of lung disorders, including inflammation, infections or cancer. Performed by a pulmonologist, EBUS bronchoscopy uses a flexible tube that goes through your mouth and into your windpipe and lungs. Similar to, though smaller than, the device used during a colonoscopy, the EBUS scope has a video camera with an ultrasound probe attached to create a local images of your lungs and nearby lymph nodes in order to accurately locate and evaluate areas seen on x-rays or scans that need a closer look.
LPI (LP Information)' newest research report, the “Endobronchial Ultrasound Biopsy Industry Forecast” looks at past sales and reviews total world Endobronchial Ultrasound Biopsy sales in 2022, providing a comprehensive analysis by region and market sector of projected Endobronchial Ultrasound Biopsy sales for 2023 through 2029. With Endobronchial Ultrasound Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Endobronchial Ultrasound Biopsy industry.
This Insight Report provides a comprehensive analysis of the global Endobronchial Ultrasound Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Endobronchial Ultrasound Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Endobronchial Ultrasound Biopsy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Endobronchial Ultrasound Biopsy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Endobronchial Ultrasound Biopsy.
The global Endobronchial Ultrasound Biopsy market size is projected to grow from US$ 517.5 million in 2022 to US$ 732.2 million in 2029; it is expected to grow at a CAGR of 5.1% from 2023 to 2029.
The main companies of Global Endobronchial Ultrasound Biopsy include Olympus, Boston Scientific, CONMED, MEDI-GLOBE, Cook Medical, etc. These top five companies hold a market share about 65%. North America and Japan are the major producing regions in the world. In terms of application, the product is most widely used in hospitals, followed by ambulatory surgical centers.
This report presents a comprehensive overview, market shares, and growth opportunities of Endobronchial Ultrasound Biopsy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Transbronchial Aspiration Needles
Biopsy Forceps
Biopsy Needles
Cytology Brushes
Spray Catheters
Segmentation by application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Diagnostic Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Olympus
Boston Scientific
CONMED
Cook Medical
CLINODEVICE
Medtronic
MEDI-GLOBE
Veran Medical
PENTAX Medical
Fujifilm
Micro Tech
AoHua
Jiuhong

Please note: The report will take approximately 2 business days to prepare and deliver.